$31.41Average Price Target
The highest estimate is 36.42.
From 6 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow 36X0.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
FAQs
What is Ascentage Pharma Group International stock price today?▼
The current price of 36X0.STU is €13.10 EUR — it has increased by +3.15% in the past 24 hours. Watch Ascentage Pharma Group International stock price performance more closely on the chart.
What is Ascentage Pharma Group International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Ascentage Pharma Group International stocks are traded under the ticker 36X0.STU.
Is Ascentage Pharma Group International stock price growing?▼
36X0.STU stock has risen by +11.02% compared to the previous week, the month change is a +3.97% rise, over the last year Ascentage Pharma Group International has showed a -52.19% decrease.
What is Ascentage Pharma Group International market cap?▼
Today Ascentage Pharma Group International has the market capitalization of 1.22B
When is the next Ascentage Pharma Group International earnings date?▼
Ascentage Pharma Group International is going to release the next earnings report on March 31, 2027.
What were Ascentage Pharma Group International earnings last quarter?▼
36X0.STU earnings for the last quarter are -0.28 EUR per share, whereas the estimation was -0.05 EUR resulting in a -483.69% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Ascentage Pharma Group International revenue for the last year?▼
Ascentage Pharma Group International revenue for the last year amounts to 69.15M EUR.
What is Ascentage Pharma Group International net income for the last year?▼
36X0.STU net income for the last year is -149.39M EUR.
How many employees does Ascentage Pharma Group International have?▼
As of November 7, 2026, the company has 828 employees.
In which sector is Ascentage Pharma Group International located?▼
Ascentage Pharma Group International operates in the Health & Wellness sector.
When did Ascentage Pharma Group International complete a stock split?▼
The last stock split for Ascentage Pharma Group International was on April 7, 2003 with a ratio of 3:1.
Where is Ascentage Pharma Group International headquartered?▼
Ascentage Pharma Group International is headquartered in Suzhou, China.